As the cancer is increasing rapidly, scientists in Pakistan are working hard to combat against this fatal disease. Director INMOL Cancer Hospital and his team feel pride in practically launching first treatment with 177Lu-DOTA-NOC, thus entering in a new era of most modern and state of the art Theranostic services with Gallium-68 PET scan followed by targeted therapy with Lu-177-DOTA-NOC. It is envisaged that this theranostic setup will bring a revolution in diagnosis and treatment of cancer patients, because it has the ability to detect and treat cancer with same type of biomolecules.
The newly developed Theranostics lab at INMOL being first such facility supported by International Atomic Energy Agency (IAEA) in the country and in Asia.
It is noted that firstly it became operational on 1st November 2017 after successful commissioning of new equipment by Mr. Bernard Mayer (German Engineer) who came to INMOL to install this setup.
The commissioning of Automatic Synthesizer and Gallium-68 generator is a landmark achievement of INMOL that became possible under supervision of Dr. Abubaker Shahid, Director INMOL and Dr. Irfan Ullah Khan, Chief Project Investigator, funded by International Atomic Energy Agency (IAEA).
Published in Daily Times, March 7th 2018.
.jpg)
.jpg)
